-------------------------------------------------------------------------------- | | Copenhagen, 23 October 2008 | -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- Pharmexa A/S - reduction in share capital by reducing face value The share capital of Pharmexa A/S will be reduced by reducing the face value of each share, cf. adoption made on the extraordinary general meeting held on 1 July 2008. The changes will be implemented on NASDAQ OMX on 28 October 2008: -------------------------------------------------------------------------------- | ISIN: | DK0015966592 | -------------------------------------------------------------------------------- | Name: | Pharmexa | -------------------------------------------------------------------------------- | Volume before reduction: | 59,691,940 shares each bearing a | | | face value of DKK 5 (DKK | | | 298,459,700) | -------------------------------------------------------------------------------- | Capital reduction: | DKK 268,613,730 | -------------------------------------------------------------------------------- | Volume after reduction: | 59,691,940 shares each bearing a | | | face value of DKK 0.50 DKK | | | (29,845,970) | -------------------------------------------------------------------------------- | New face value: | DKK 0.50 | -------------------------------------------------------------------------------- | Short name: | PHARMX | -------------------------------------------------------------------------------- For further information, please see announcements from Pharmexa, e.g. announcement of 22 October 2008. For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66